TriSalus Life Sciences, Inc. (TLSI)

TriSalus Life Sciences, Inc. in the Healthcare sector is trading at $3.59 with a market capitalization of $294M. Wall Street consensus targets $10.40 (5 analysts), implying a +189.7% move over the next 12 months. The stock is currently 55% below its 52-week high of $7.95, remaining 19.5% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 18 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.